Potent COVID-19 Antibodies to Beat Omicron & Save Lives
Monoclonal Antibodies Against COVID-19
Tags: University of Melbourne, Australia, Healthcare & Lifesciences
University of Melbourne researchers developed human monoclonal antibodies showing potent activity against major SARS-CoV-2 variants, including Omicron. These antibodies, effective in vitro and in animal models, aim to treat severe COVID-19 and offer protection to immunocompromised individuals. They represent a critical advancement in neutralizing emerging variants that current vaccines and monoclonals struggle against. The technology could significantly impact therapeutic approaches for COVID-19, especially for those at high risk.
IP Type or Form Factor: Patent Pending; Platform
TRL: 6 - prototype validated in intended environment
Industry or Tech Area: Biotechnology; Pharmaceutical Engineering
